Company Profiles

driven by the PitchBook Platform

Athera Biotechnologies

Description

Developer of targeted anti-inflammatory biological candidate drugs. The company develops targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease.

2005

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$2.82M

Latest Deal Amount

$2.82M

Total Amount Raised

Description

Developer of targeted anti-inflammatory biological candidate drugs. The company develops targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease.

Website:

www.athera.se

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Sankt Eriksgatan 117 4th Floor 113 43 StockholmSweden +46 (0)7 619 38 190
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Athera Biotechnologies's full profile, request a free trial.

Athera Biotechnologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Athera Biotechnologies Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
European Union FP7Other000 0000000 0000
IndustrifondenVenture CapitalMinority000 0000000 0000
Karolinska DevelopmentVenture CapitalMajority000 0000000 0000
ÖstersjöstiftelsenOtherMinority000 0000000 0000
European Union FP7 Other
Industrifonden Venture Capital
Karolinska Development Venture Capital
Östersjöstiftelsen Other

Athera Biotechnologies Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Carina SchmidtChief Executive Officer
Knut Pettersson Ph.DChief Scientific Officer
Anders Bergman Ph.DVice President IP and Legal
Tommy AbrahamssonSenior Advisor CVD Pharmaceuticals
Carina Schmidt Chief Executive Officer
Knut Pettersson Ph.D Chief Scientific Officer
Anders Bergman Ph.D Vice President IP and Legal
Tommy Abrahamsson Senior Advisor CVD Pharmaceuticals

Athera Biotechnologies Board Members (4)

NameRepresentingRoleSinceContact
Info
Gunnar Olsson Ph.DSelfChairman of the Board000 0000
Jonas Brambeck Ph.DIndustrifondenInvestment Manager Life Science000 0000
Otto SkollingSelfDirector of the Board000 0000
Svein Arild MathisenSelfBoard Member000 0000
Gunnar Olsson Ph.D Chairman of the Board Self
Jonas Brambeck Ph.D Investment Manager Life Science Industrifonden
Otto Skolling Director of the Board Self
Svein Arild Mathisen Board Member Self
Request full access to PitchBook